EndoTheia has completed the clinical trial of its FlexStone Basket, an independently steerable device, designed for kidney stone removal.
This technology marks a significant advancement in urological care by providing surgeons with enhanced precision and control during kidney stone removal procedures.
Go deeper with GlobalData
The first-in-human trial was carried out at Vanderbilt University Medical Center by co-lead investigators Dr Nicholas Kavoussi and Dr Ryan Hsi.
With the FlexStone Basket, surgeons will have direct control over the device, facilitating improved navigation around anatomical structures to access stones located in challenging areas within the kidney.
This feature overcomes the longstanding constraints of traditional kidney stone extraction devices, potentially enhancing patient results and simplifying the procedure.
Kavoussi said: “The FlexStone Basket offers unprecedented flexibility and control, enabling us to access and retrieve stones in challenging locations that would otherwise be difficult to reach.”
How well do you really know your competitors?
Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.
Thank you!
Your download email will arrive shortly
Not ready to buy yet? Download a free sample
We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form
By GlobalDataEndoTheia has formed a strategic alliance with Nissha Medical Technologies to facilitate FlexStone Basket’s commercial expansion and promote advancements in minimally invasive endoscopic techniques.
With this collaboration, the company can expedite its innovation pipeline and facilitate the quick introduction of solutions to the market while enhancing surgical capabilities worldwide.
EndoTheia president Robert Webster said: “The successful first-in-human trial of the FlexStone Basket is a testament to EndoTheia’s commitment to pioneering transformative medical devices that empower physicians and improve patient care.
“We are thrilled to be working with leading experts at Vanderbilt University on this groundbreaking achievement and look forward to bringing this technology to healthcare providers worldwide.”
Building on FlexStone’s success, the company plans to introduce an independently steerable laser fibre designed to enhance access and precision at the time of lithotripsy procedures.
The FlexStone Basket study data will be shared at the American Urological Association Annual Meeting in Las Vegas, Nevada, to be held from 26 to 30 April 2025.
